Universal Health Services 'B'

At the Morgan Stanley Healthcare Conference, Universal Health Services announced a strategic shift toward more outpatient and digital psychiatric offerings, supported by the $835 million acquisition of Talkspace and the Thousand Branches initiative. The company trimmed its full‑year guidance by about $50 million within the range but still expects roughly 3% EBITDA growth and about 6% EPS growth. UHS sees solid acute‑care volumes, plans no major new hospital builds, intends to use AI to boost billing efficiency, and will continue share buybacks and disciplined capital allocation. » More on de.investing.com

Universal Health Services reported at the Wells Fargo conference slower but still positive growth and lowered its full-year guidance for adjusted admissions to 1.5–2.5%. The company now expects an $85 million hit from changes in the insurance market and has adjusted full-year mid‑point EBITDA down by about 3%, but still sees roughly 3% EBITDA growth year over year. UHS is expanding capacity (including 177 new beds) and bolstering outpatient psychiatry through the acquisition of Talkspace and the "Thousand Branches" initiative, but continues to face headwinds in surgical services and from market/political factors. » More on de.investing.com

S&P Global Ratings has raised the outlook for Universal Health Services from “stable” to “positive” and affirmed the issuer rating at “BB+”. For planned senior notes S&P assigned an issue rating of “BBB-” and a recovery rating of “2”. The agency sees room for an upgrade if UHS keeps leverage in the 2.0–3.0x range; the issue is intended to refinance a Sept. 2026 bond of $700m and to finance parts of the Talkspace acquisition. S&P expects slower revenue growth in 2026–2027, a slightly lower adjusted EBITDA margin in 2026, and share buybacks of about $800m in 2026 (up to $1.3bn in 2027), and sees leverage below 2.5x in 2026/2027. » More on de.investing.com